Executive Vice President and General Manager, In Vitro Diagnostics (IVD) and EMEA Organizations
Stephane Debono is Executive Vice President and General Manager, In Vitro Diagnostics (IVD) and EMEA Organizations for Veracyte, overseeing development, manufacturing, market access, sales and marketing of the company’s IVD tests, which serve physicians and their patients in global markets. Mr. Debono is a seasoned executive and entrepreneur who brings more than 25 years of life sciences and healthcare experience to Veracyte. He most recently served as the company’s General Manager of Immunoscore and International Diagnostics Operations. He previously served as Deputy Chief Executive Officer of HalioDx prior to its acquisition by Veracyte in August 2021. Mr. Debono co-founded Ipsogen in 1999 and successfully developed and managed the company’s operations, including services and product manufacturing, as well as its finances and shareholder reporting. Following Ipsogen’s acquisition by Qiagen in 2011, Mr. Debono oversaw European molecular diagnostics manufacturing operations for Qiagen’s IVD products in cancer and infectious diseases. Mr. Debono holds an Engineering degree from École Centrale de Marseille and a Master’s degree in Finance from Euromed Marseille.